21632533

Summary
Title
Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.
Authors
  • Watanabe M
  • Horai Y
  • Houten SM
  • Morimoto K
  • Sugizaki T
  • Arita E
  • Mataki C
  • Sato H
  • Tanigawara Y
  • Schoonjans K
  • Itoh H
  • Auwerx J
Source
J Biol Chem
Publication Date
2011 Jul 29
PubMed ID
21632533

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024